Targeting NRF2-dependent GSH synthesis was effective in the metastatic model of SDHB-silenced PHEO/PGL [35], thus, more strategies to prevent the overall production and/or availability of GSH in tumor cells may be beneficial in future PHEO/PGL therapies. Here, NFE2L2 is linked to neoplasm.